Cargando…
Challenges for Managed Care from 340B Contract Pharmacies
The federal 340B Drug Pricing Program has expanded rapidly, with important yet still unmeasured impact on both managed care practice and policies. Notably, providers increasingly rely on external, contract pharmacies to extend 340B pricing to a broad set of patients. In 2014, 1 in 4 U.S. retail, mai...
Autor principal: | Fein, Adam J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398234/ https://www.ncbi.nlm.nih.gov/pubmed/27003548 http://dx.doi.org/10.18553/jmcp.2016.22.3.197 |
Ejemplares similares
-
Milestones in managed care pharmacy
por: Cantrell, Susan, et al.
Publicado: (2020) -
Trends in 340B Drug Pricing Program Contract Growth Among Retail Pharmacies From 2009 to 2022
por: Nikpay, Sayeh, et al.
Publicado: (2023) -
Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics
por: Lin, John K., et al.
Publicado: (2022) -
Anticipated efficiencies, real costs: Medicaid managed care organizations and the pharmacy benefit
por: Bendicksen, Liam, et al.
Publicado: (2022) -
Application of a Graphical Depiction of Longitudinal Study Designs to Managed Care Pharmacy Research
por: Happe, Laura E., et al.
Publicado: (2020)